Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2021 Results Conference Call March 10, 2022 4:30 PM ET Company Participants Jenny Kobin - Investor Relations George Lasezkay - Chief Executive Officer Dr. Thomas Ciulla - Chief Medical Officer and Chief Development Officer Charlie Deignan - Chief Financial Officer Conference Call Participants Annabel Samimy - Stifel Andreas Argyrides - Wedbush Zegbeh Jallah - ROTH Capital Partners Rohit Basin - Needham Jon Wolleben - JMP Securities Operator Good day. Thank you for ...